Sino Biopharmaceutical (SBMFF)
(Delayed Data from OTC)
$0.38 USD
0.00 (0.00%)
Updated Aug 19, 2024 12:12 PM ET
3-Hold of 5 3
B Value D Growth D Momentum C VGM
Cash flow Statements
Fiscal Year End for Sino Biopharmaceutical falls in the month of December.
All data in Millions except Per Share data.
Cash Flow From Operations, Investments & Financial Activities
12/31/2023 | 12/31/2022 | 12/31/2021 | 12/31/2020 | 12/31/2019 | |
---|---|---|---|---|---|
Cash Flow From Operations, Investments & Financial Activities |
|||||
Net Income (Loss) | NA | NA | NA | 726.39 | 807.98 |
Depreciation/Amortization & Depletion | NA | NA | NA | 228.95 | 212.13 |
Net Change from Assets/Liabilities | NA | NA | NA | 37.87 | -40.32 |
Net Cash from Discontinued Operations | NA | NA | NA | 0.00 | 0.00 |
Other Operating Activities | NA | NA | NA | -221.56 | -209.32 |
Net Cash From Operating Activities | NA | NA | NA | 771.64 | 770.47 |
Property & Equipment | NA | NA | NA | -191.72 | -200.61 |
Acquisition/ Disposition of Subsidiaries | NA | NA | NA | 0.00 | -7.13 |
Investments | NA | NA | NA | -912.67 | -133.73 |
Other Investing Activities | NA | NA | NA | -32.43 | -211.91 |
Net Cash from Investing Activities | NA | NA | NA | -1,136.82 | -553.38 |
Uses of Funds
12/31/2023 | 12/31/2022 | 12/31/2021 | 12/31/2020 | 12/31/2019 | |
---|---|---|---|---|---|
Issuance (Repurchase) of Capital Stock | NA | NA | NA | -28.31 | -4.64 |
Issuance (Repayment) of Debt | NA | NA | NA | 822.08 | 0.00 |
Increase (Decrease) Short-Term Debt | NA | NA | NA | -39.35 | 747.38 |
Payment of Dividends & Other Distributions | NA | NA | NA | -393.34 | -292.42 |
Other Financing Activities | NA | NA | NA | -37.48 | -45.04 |
Net Cash from Financing Activities | NA | NA | NA | 323.59 | 405.28 |
Effect of Exchange Rate Changes | NA | NA | NA | 40.57 | 13.75 |
Net Change In Cash & Equivalents | NA | NA | NA | -1.02 | 636.13 |
Cash at Beginning of Period | NA | NA | NA | 1,540.46 | 902.21 |
Cash at End of Period | NA | NA | NA | 1,539.45 | 1,538.34 |
Diluted Net EPS | NA | NA | NA | 0.02 | 0.02 |
Fiscal Year End for Sino Biopharmaceutical falls in the month of December.
All data in Millions except Per Share data.
Cash Flow From Operations, Investments & Financial Activities
6/30/2024 | 3/31/2024 | 12/31/2023 | 9/30/2023 | 6/30/2023 | |
---|---|---|---|---|---|
Cash Flow From Operations, Investments & Financial Activities |
|||||
Net Income (Loss) | NA | NA | NA | NA | NA |
Depreciation/Amortization & Depletion | NA | NA | NA | NA | NA |
Net Change from Assets/Liabilities | NA | NA | NA | NA | NA |
Net Cash from Discontinued Operations | NA | NA | NA | NA | NA |
Other Operating Activities | NA | NA | NA | NA | NA |
Net Cash From Operating Activities | NA | NA | NA | NA | NA |
Property & Equipment | NA | NA | NA | NA | NA |
Acquisition/ Disposition of Subsidiaries | NA | NA | NA | NA | NA |
Investments | NA | NA | NA | NA | NA |
Other Investing Activities | NA | NA | NA | NA | NA |
Net Cash from Investing Activities | NA | NA | NA | NA | NA |
Uses of Funds
6/30/2024 | 3/31/2024 | 12/31/2023 | 9/30/2023 | 6/30/2023 | |
---|---|---|---|---|---|
Issuance (Repurchase) of Capital Stock | NA | NA | NA | NA | NA |
Issuance (Repayment) of Debt | NA | NA | NA | NA | NA |
Increase (Decrease) Short-Term Debt | NA | NA | NA | NA | NA |
Payment of Dividends & Other Distributions | NA | NA | NA | NA | NA |
Other Financing Activities | NA | NA | NA | NA | NA |
Net Cash from Financing Activities | NA | NA | NA | NA | NA |
Effect of Exchange Rate Changes | NA | NA | NA | NA | NA |
Net Change In Cash & Equivalents | NA | NA | NA | NA | NA |
Cash at Beginning of Period | NA | NA | NA | NA | NA |
Cash at End of Period | NA | NA | NA | NA | NA |
Diluted Net EPS | NA | NA | NA | NA | NA |